Order Article Reprints

Koehm M, Foldenauer AC, Rossmanith T, Alten R, Aringer M, Backhaus M, Burmester GR, Feist E, Kellner H, Krueger K, et al. Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of Clinical Medicine. 2022; 11(24):7316. https://doi.org/10.3390/jcm11247316

Koehm, Michaela, Ann C. Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R. Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, and et al. 2022. "Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)" Journal of Clinical Medicine 11, no. 24: 7316. https://doi.org/10.3390/jcm11247316

Koehm, M., Foldenauer, A. C., Rossmanith, T., Alten, R., Aringer, M., Backhaus, M., Burmester, G. R., Feist, E., Kellner, H., Krueger, K., Müller-Ladner, U., Rubbert-Roth, A., Tony, H.-P., Wassenberg, S., Burkhardt, H., & Behrens, F. (2022). Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of Clinical Medicine, 11(24), 7316. https://doi.org/10.3390/jcm11247316